PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1996; 89(Suppl 29): 3–12.
PMCID: PMC1295600

A tribute to professor Geoffrey D Chisholm CBE ChM PPRCS Ed FRCS Eng FRCP Ed FRCPSG FRACS (Hon) FCSSA (Hon) FACS (Hon) FRSE.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.8M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • CHISHOLM GD. The Scribner arteriovenous fistula for haemodialysis. Br Med J. 1961 Jul 1;2(5243):30–33. [PMC free article] [PubMed]
  • Chisholm GD. Obstructive uropathy--a review of 146 patients with postrenal uraemia. S Afr Med J. 1967 Oct 7;41(38):962–964. [PubMed]
  • Chisholm GD, Rivero OR, Calnan JS. The permeability of the renal pelvis during ureteric obstruction. Br J Surg. 1967 Dec;54(12):1023–1026. [PubMed]
  • Holroyd AM, Chisholm GD, Glass HI. The quantitative analysis of renograms using the gamma camera. Phys Med Biol. 1970 Jul;15(3):483–492. [PubMed]
  • Chisholm GD, Aye MM, Evans K. Evaluation of the Hg197 chlormerodrin kidney scan. Br J Urol. 1967 Feb;39(1):38–49. [PubMed]
  • Chisholm GD, Aye MM. Kidney scanning: the clinical use of 197Hg chlormerodrin and 99m Tc iron complex. Proc R Soc Med. 1967 Sep;60(9):869–871. [PMC free article] [PubMed]
  • Chisholm GD, Evans K, Kulatilake AE. The quantitation of renal blood flow using I-125 hippuran. An experimental study in the perfusion of the isolated canine kidney. Br J Urol. 1967 Feb;39(1):50–57. [PubMed]
  • Short MD, Glass HI, Chisholm GD, Vernon P, Silvester DJ. Gamma-camera renography using 123I-hippuran. Br J Radiol. 1973 Apr;46(544):289–294. [PubMed]
  • Ram MD, Holroyd M, Chisholm GD. Measurement of glomerular filtration-rate using 131-I-diatrizoate. Lancet. 1969 Feb 22;1(7591):397–399. [PubMed]
  • Chibber PJ, Chisholm GD, Hargreave TB, Merrick MV. 99mTechnetium DMSA and the prediction of recovery in obstructive uropathy. Br J Urol. 1981 Dec;53(6):492–495. [PubMed]
  • Chisholm GD, Chibber PJ, Wallace DM, Hargreave TB, Merrick MV. DMSA scan and the prediction of recovery in obstructive uropathy. Eur Urol. 1982;8(4):227–230. [PubMed]
  • Chisholm GD, Roy RR. The systemic effects of malignant renal tumours. Br J Urol. 1971 Dec;43(6):687–700. [PubMed]
  • Das G, Chisholm GD, Sherwood T. Can angiography stage renal carcinoma? Br J Urol. 1977;49(7):611–614. [PubMed]
  • Ritchie AW, Kemp IW, Chisholm GD. Is the incidence of renal carcinoma increasing? Br J Urol. 1984 Dec;56(6):571–573. [PubMed]
  • Ritchie AW, Chisholm GD. Management of renal carcinoma--a questionnaire survey. Br J Urol. 1983 Dec;55(6):591–594. [PubMed]
  • WOODRUFF MF, ROBSON JS, ROSS JA, NOLAN B, LAMBIE AT. Transplantation of a kidney from an identical twin. Lancet. 1961 Jun 10;1(7189):1245–1249. [PubMed]
  • Chisholm GD. Time to end softly softly approach on harvesting organs for transplantation. Br Med J (Clin Res Ed) 1988 May 21;296(6634):1419–1420. [PMC free article] [PubMed]
  • Notghi A, Dick J, Smith G, Anderton JL, Chisholm GD. A comparison of cyclosporin versus azathioprine treatment in renal transplants in Edinburgh. Scott Med J. 1989 Jun;34(3):459–462. [PubMed]
  • Notghi A, Anderton JL, Chisholm GD, Hamer-Hodges D, Wilkinson S, Smith G, Galloway NT, Yap PL, Winney RJ. Effect of a blood transfusion protocol and low dose steroid regime on renal transplant survival. Scott Med J. 1986 Apr;31(2):94–98. [PubMed]
  • CHISHOLM GD, HEARD BE. Oxalosis. Br J Surg. 1962 Jul;50:78–92. [PubMed]
  • Williams G, Chisholm GD. Stone screening and follow-up are necessary? Br J Urol. 1975;47(7):745–750. [PubMed]
  • Ram MD, Chisholm GD. Cystic disease of renal pyramids (medullary sponge kidney). Br J Urol. 1969 Jun;41(3):280–286. [PubMed]
  • Chisholm GD, Cooter NB, Dawson JM. Primary amyloidosis of the renal pelvis. Br Med J. 1967 Mar 25;1(5542):736–738. [PMC free article] [PubMed]
  • Chisholm GD, Shackman R. Malignant obstructive uraemia. Br J Urol. 1968 Dec;40(6):720–726. [PubMed]
  • Thomas MH, Chisholm GD. Retroperitoneal fibrosis associated with malignant disease. Br J Cancer. 1973 Nov;28(5):453–458. [PMC free article] [PubMed]
  • Kulatilake AE, Chisholm GD, Olsen EG. In-situ carcinoma of the urinary bladder. Proc R Soc Med. 1970 Jan;63(1):95–97. [PMC free article] [PubMed]
  • Riddle PR, Chisholm GD, Trott PA, Pugh RC. Flat carcinoma in Situ of bladder. Br J Urol. 1975;47(7):829–833. [PubMed]
  • el-Demiry MI, Smith G, Ritchie AW, James K, Cumming JA, Hargreave TB, Chisholm GD. Local immune responses after intravesical BCG treatment for carcinoma in situ. Br J Urol. 1987 Dec;60(6):543–548. [PubMed]
  • Cumming JA, Hargreave TB, Webb JN, McIntyre MA, Chisholm GD. Intravesical Evans Bacille Calmette-Guérin in the treatment of carcinoma in situ. Br J Urol. 1989 Mar;63(3):259–263. [PubMed]
  • Wallace DM, Hindmarsh JR, Webb JN, Busuttil A, Hargreave TB, Newsam JE, Chisholm GD. The role of multiple mucosal biopsies in the management of patients with bladder cancer. Br J Urol. 1979 Dec;51(6):535–540. [PubMed]
  • Smith G, Elton RA, Beynon LL, Newsam JE, Chisholm GD, Hargreave TB. Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer. Br J Urol. 1983 Dec;55(6):665–669. [PubMed]
  • Smith G, Theodorou C, Field G, Hargreave TB, Chisholm GD. Intravesical methotrexate in the treatment of superficial bladder cancer. Br J Urol. 1984 Dec;56(6):663–667. [PubMed]
  • Chisholm GD, Hindmarsh JR, Howatson AG, Webb JN, Busuttil A, Hargreave TB, Newsam JE. TNM (1978) in bladder cancer: use and abuse. Br J Urol. 1980 Dec;52(6):500–505. [PubMed]
  • Chibber PJ, McIntyre MA, Hindmarsh JR, Hargreave TB, Newsam JE, Chisholm GD. Transitional cell carcinoma involving the prostate. Br J Urol. 1981 Dec;53(6):605–609. [PubMed]
  • Quilty PM, Duncan W, Chisholm GD, Fowler JW, Hargreave TB, Newsam JE, Tolley DA. Results of surgery following radical radiotherapy for invasive bladder cancer. Br J Urol. 1986 Aug;58(4):396–405. [PubMed]
  • Whillis D, Howard GC, Kerr GR, Fowler J, Hargreave TB, Chisholm GD. Radical radiotherapy with salvage surgery for invasive bladder cancer: results following a reduction in radiation dose. J R Coll Surg Edinb. 1992 Feb;37(1):42–45. [PubMed]
  • el-Demiry MI, Hargreave TB, Busuttil A, James K, Ritchie AW, Chisholm GD. Lymphocyte sub-populations in the male genital tract. Br J Urol. 1985 Dec;57(6):769–774. [PubMed]
  • el-Demiry MI, Hargreave TB, Busuttil A, Elton R, James K, Chisholm GD. Immunocompetent cells in human testis in health and disease. Fertil Steril. 1987 Sep;48(3):470–479. [PubMed]
  • Prescott S, James K, Busuttil A, Hargreave TB, Chisholm GD, Smyth JF. HLA-DR expression by high grade superficial bladder cancer treated with BCG. Br J Urol. 1989 Mar;63(3):264–269. [PubMed]
  • Jackson AM, Hawkyard SJ, Prescott S, Ritchie AW, James K, Chisholm GD. An investigation of factors influencing the in vitro induction of LAK activity against a variety of human bladder cancer cell lines. J Urol. 1992 Jan;147(1):207–211. [PubMed]
  • Hawkyard SJ, Jackson AM, James K, Prescott S, Smyth JF, Chisholm GD. The inhibitory effects of interferon gamma on the growth of bladder cancer cells. J Urol. 1992 May;147(5):1399–1403. [PubMed]
  • Hawkyard S, James K, Prescott S, Jackson AM, Ritchie AW, Smyth JF, Chisholm GD. The effects of recombinant human interferon-gamma on a panel of human bladder cancer cell lines. J Urol. 1991 May;145(5):1078–1081. [PubMed]
  • Hawkyard SJ, Jackson AM, Hawkins RA, James K, Smyth JF, Chisholm GD. Expression of interferon-gamma receptors on bladder cancer cells: does it correlate with biological response? Urol Res. 1992;20(3):229–232. [PubMed]
  • Hawkyard SJ, Jackson AM, Prescott S, James K, Chisholm GD. The effect of recombinant cytokines on bladder cancer cells in vitro. J Urol. 1993 Aug;150(2 Pt 1):514–518. [PubMed]
  • Jackson AM, Hawkyard SJ, Prescott S, Ritchie AW, James K, Chisholm GD. An investigation of factors influencing the in vitro induction of LAK activity against a variety of human bladder cancer cell lines. J Urol. 1992 Jan;147(1):207–211. [PubMed]
  • Esuvaranathan K, Alexandroff AB, McIntyre M, Jackson AM, Prescott S, Chisholm GD, James K. Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy. J Urol. 1995 Aug;154(2 Pt 1):572–575. [PubMed]
  • Jackson AM, Alexandrov AB, Prescott S, James K, Chisholm GD. Expression of adhesion molecules by bladder cancer cells: modulation by interferon-gamma and tumour necrosis factor-alpha. J Urol. 1992 Nov;148(5):1583–1586. [PubMed]
  • Jackson AM, Alexandrov AB, Prescott S, James K, Chisholm GD. Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1. Immunology. 1992 Jun;76(2):286–291. [PubMed]
  • Roy RR, Nathan BE, Beales JS, Chisholm GD. 18 fluorine total body scans in patients with carcinoma of the prostate. Br J Urol. 1971 Feb;43(1):58–64. [PubMed]
  • Galasko CS, Westerman B, Sellwood RA, Burn JI. Use of the gamma camera for early detection of osseous metastases from mammary cancer. Br J Surg. 1968 Aug;55(8):613–615. [PubMed]
  • Buck AC, Chisholm GD, Merrick MV, Lavender JP. Serial Fluorine-18 bone scans in the follow-up of carcinoma of the prostate. Br J Urol. 1975 Jun;47(3):287–294. [PubMed]
  • Chisholm GD, Stone AR, Beynon LL, Merrick MV. The bone scan as a tumour marker in prostatic carcinoma. Eur Urol. 1982;8(5):257–260. [PubMed]
  • Chisholm GD, Short MD, Ghanadian R, McRae CU, Glass HI. Radiozinc uptake and scintiscanning in prostatic disease. J Nucl Med. 1974 Sep;15(9):739–742. [PubMed]
  • Stone AR, Merrick MV, Chisholm GD. Prostatic lymphoscintigraphy. Br J Urol. 1979 Dec;51(6):556–560. [PubMed]
  • Chisholm GD, O'Donoghue EP, Kennedy CL. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate. Br J Urol. 1977;49(7):717–720. [PubMed]
  • Stone AR, Hargreave TB, Chisholm GD. The diagnosis of oestrogen escape and the role of secondary orchiectomy in prostatic cancer. Br J Urol. 1980 Dec;52(6):535–538. [PubMed]
  • Goodman CM, Busuttil A, Chisholm GD. Age, and size and grade of tumour predict prognosis in incidentally diagnosed carcinoma of the prostate. Br J Urol. 1988 Dec;62(6):576–580. [PubMed]
  • Rana A, Chisholm GD, Christodoulou S, McIntyre MA, Elton RA. Audit and its impact in the management of early prostatic cancer. Br J Urol. 1993 Jun;71(6):721–727. [PubMed]
  • Rana A, Chisholm GD, Christodoulou S, McIntyre M, Elton RA. Audit and its impact in the management of advanced prostatic cancer. Br J Urol. 1993 Oct;72(4):478–483. [PubMed]
  • Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW, Chisholm GD, Moskovitz B, Livne PM, Warner J. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994 Jan 27;330(4):242–248. [PubMed]
  • Chisholm GD. Prostate cancer screening: accepting the consequences of PSA testing. Br J Urol. 1993 Apr;71(4):375–377. [PubMed]
  • McRae CU, Ghanadian R, Fotherby K, Chisholm GD. The effect of testosterone on the human prostate in organ culture. Br J Urol. 1973 Apr;45(2):156–162. [PubMed]
  • Ghanadian R, Chisholm GD, Ansell ID. 5alpha-dihydrotestosterone stimulation of human prostate in organ culture. J Endocrinol. 1975 May;65(2):253–258. [PubMed]
  • Ghanadian R, Lewis JG, Chisholm GD, O'Donoghue EP. Serum dihydrotestosterone in patients with benign prostatic hypertrophy. Br J Urol. 1977 Nov;49(6):541–544. [PubMed]
  • Ghanadian R, Smith CB, Williams G, Chisholm GD. The effect of antiandrogens and stilboestrol on the cytosol receptor in rat prostate. Br J Urol. 1977;49(7):695–700. [PubMed]
  • Ghanadian R, Holland JM, Chisholm GD. Identification of a prostate in female praomys (Mastomys) natalensis using 3-H steroids. Br J Urol. 1975 Feb;47(1):77–82. [PubMed]
  • Ghanadian R, Holland JM, Chisholm GD. Uptake and distribution of 3H testosterone in tissues of male Praomys (Mastomys) Natalensis: an in vivo and in vitro study on the prostate. Urol Res. 1976 Jul 23;4(2):77–81. [PubMed]
  • Ghanadian R, Lewis JG, Chisholm GD. Androgen concentrations in prostate and serum of the male and female Praomys (Mastomys) natalensis. Invest Urol. 1977 Nov;15(3):212–214. [PubMed]
  • Ghanadian R, Smith CB, Chisholm GD, Blacklock NJ. Differential androgen uptake by the lobes of the rhesus monkey prostate. Br J Urol. 1977;49(7):701–704. [PubMed]
  • Yang Y, Chisholm GD, Habib FK. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels. Br J Cancer. 1993 Jan;67(1):152–155. [PMC free article] [PubMed]
  • Habib FK, Busuttil A, Robinson RA, Chisholm GD. 5 Alpha-reductase activity in human prostate cancer is related to the histological differentiation of the tumour. Clin Endocrinol (Oxf) 1985 Oct;23(4):431–438. [PubMed]
  • Habib FK, Bissas A, Neill WA, Busuttil A, Chisholm GD. Flow cytometric analysis of cellular DNA in human prostate cancer: relationship to 5 alpha-reductase activity of the tissue. Urol Res. 1989;17(4):239–243. [PubMed]
  • Rana A, Chisholm GD. He sold his bike for a low prostate specific antigen. J Urol. 1994 Mar;151(3):700–700. [PubMed]
  • Calnan JS, Pflug JJ, Chisholm GD, Taylor LM. Pathophysiology of tissue fluid. Proc R Soc Med. 1972 Aug;65(8):715–719. [PMC free article] [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press